CSPG4 and neoplasm: Likewise, the reprogrammed CSPG4 CAR T cell (RP-CSPG4 CAR T cell) treatment caused complete tumor regression of orthotopic TNBC SUM149 cell line-derived solid tumors in 100% of mice.